Skip to content

SAVE Studie-SArcoma Surgery with Vacuum Enhanced wound treatment Randomised controlled Study to evaluate the wound management in sarcoma surgery

SAVE Studie-SArcoma Surgery with Vacuum Enhanced wound treatment Randomised controlled Study to evaluate the wound management in sarcoma surgery - SAVE

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036065
Enrollment
100
Registered
2025-01-31
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C49

Interventions

Group 1: Control Group: Primary Closure after Resection of Sarcoma Group 2: Intervention Group: Vacuum-Therapy after sarcoma resection with secondary wound closure

Sponsors

Universitätsklinikum Hamburg- Eppendorf
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients must be over 18 years old. - Patients of any gender and background - The largest tumor diameter on imaging must be at least 5 cm. Preoperative imaging is required to assess tumor dimensions. - Sarcomas must be located in the lower extremity or groin. - Cases must be discussed preoperatively at an interdisciplinary tumor board. - Patients must provide informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: - Tumors smaller than 5 cm and superficial masses. - Patients with local recurrences or prior wound healing complications in the surgical area. - Patients with ulcerating or infected tumors, or those requiring emergency surgery. - Other Soft Tissue Tumors such as Kaposi sarcoma. - When direct closure is not possible during the initial surgery due to the extent of resection.

Design outcomes

Primary

MeasureTime frame
The primary objective of the study is to compare wound complications after vacuum therapy versus direct closure. The primary endpoint is defined by the occurrence of any of the following: • Infection • Seroma • Abscess • Lymphatic fistula • Wound dehiscence • Revision surgery • Drainage secretion of >50ml/24h after 5 postoperative days

Secondary

MeasureTime frame
Factors Influencing Wound Infection: - Use of drainage - Impact of different sarcoma entities - BMI, age, and smoking, as well as pre-existing conditions such as diabetes mellitus, cardiovascular diseases, and immunosuppression - Localization (difference between groin, upper, and lower leg) - Tumor size (difference between 5-10 cm and >10 cm)

Countries

Germany, Netherlands, Switzerland

Contacts

Public ContactSimone Schewe

Universitätsklinikum Hamburg Eppendorf

s.schewe@uke.de+4917684890008

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026